Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Conditions: Lung Non-Small Cell Carcinoma Interventions: Biological: Amivantamab; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging Sponsors: SWOG Cancer Research Network; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | CT Scan | Genetics | Lung Cancer | MRI Scan | Non-Small Cell Lung Cancer | Research